Axil Brands Financials
This page shows Axil Brands (AXIL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Axil Brands has an operating margin of 4.4%, meaning the company retains $4 of operating profit per $100 of revenue. This below-average margin results in a low score of 22/100, suggesting thin profitability after operating expenses. This is down from 5.5% the prior year.
Axil Brands's revenue declined 4.5% year-over-year, from $27.5M to $26.3M. This contraction results in a growth score of 16/100.
Axil Brands carries a low D/E ratio of 0.01, meaning only $0.01 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 3.76, Axil Brands holds $3.76 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.
Axil Brands has a free cash flow margin of 6.5%, earning a moderate score of 33/100. The company generates positive cash flow after capital investments, but with room for improvement.
Axil Brands's ROE of 8.8% shows moderate profitability relative to equity, earning a score of 35/100. This is down from 26.0% the prior year.
Axil Brands scores 10.53, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($40.0M) relative to total liabilities ($3.2M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Axil Brands passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Axil Brands generates $2.26 in operating cash flow ($1.9M OCF vs $855K net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Axil Brands generated $26.3M in revenue in fiscal year 2025. This represents a decrease of 4.5% from the prior year.
Axil Brands's EBITDA was $1.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 19.8% from the prior year.
Axil Brands generated $1.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 1363.3% from the prior year.
Axil Brands reported $855K in net income in fiscal year 2025. This represents a decrease of 57.3% from the prior year.
Axil Brands earned $0.10 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 52.4% from the prior year.
Axil Brands held $4.8M in cash against $140K in long-term debt as of fiscal year 2025.
Axil Brands had 7M shares outstanding in fiscal year 2025. This represents an increase of 4.1% from the prior year.
Axil Brands's gross margin was 71.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.4 percentage points from the prior year.
Axil Brands's operating margin was 4.4% in fiscal year 2025, reflecting core business profitability. This is down 1.0 percentage points from the prior year.
Axil Brands's net profit margin was 3.3% in fiscal year 2025, showing the share of revenue converted to profit. This is down 4.0 percentage points from the prior year.
Axil Brands's ROE was 8.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 17.2 percentage points from the prior year.
Axil Brands invested $213K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 54.2% from the prior year.
AXIL Income Statement
| Metric | Q2'26 | Q1'26 | Q3'25 | Q2'24 | Q2'25 | Q1'24 | Q2'23 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.1M+18.6% | $6.9M-1.0% | $6.9M+2.8% | $6.7M-20.1% | $8.4M+37.9% | $6.1M+1136.5% | $494K-91.3% | $5.7M |
| Cost of Revenue | $2.6M+17.0% | $2.2M+13.6% | $2.0M+15.5% | $1.7M-21.8% | $2.2M+48.3% | $1.5M+1193.2% | $113K-92.2% | $1.4M |
| Gross Profit | $5.5M+19.4% | $4.6M-6.7% | $5.0M-1.4% | $5.0M-19.5% | $6.3M+34.6% | $4.6M+1119.8% | $381K-91.0% | $4.2M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $494K+14.1% | $433K+10.4% | $392K+68.7% | $233K-44.9% | $422K-24.6% | $560K+822.3% | $61K-75.8% | $251K |
| Operating Income | $903K+119.3% | $412K-29.4% | $583K-40.8% | $985K-22.1% | $1.3M+627.4% | $174K+3417.9% | -$5K-102.4% | $217K |
| Interest Expense | $1K+1.6% | $1K+0.9% | $1K-27.6% | $2K+7.0% | $2K-0.2% | $2K+4.8% | $2K-8.5% | $2K |
| Income Tax | $233K+102.6% | $115K+116.7% | $53K-79.7% | $261K-28.4% | $364K+452.2% | $66K | N/A | $60K |
| Net Income | $705K+110.9% | $334K-42.0% | $577K-20.7% | $727K-28.6% | $1.0M+559.2% | $154K+447.7% | $28K-82.6% | $162K |
| EPS (Diluted) | $0.09+125.0% | $0.04-42.9% | $0.07 | $0.00 | $0.05+400.0% | $0.01 | $0.00-100.0% | $0.01 |
AXIL Balance Sheet
| Metric | Q2'26 | Q1'26 | Q3'25 | Q2'24 | Q2'25 | Q1'24 | Q2'23 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.2M+5.8% | $15.4M+18.6% | $13.0M+18.0% | $11.0M-16.4% | $13.1M+20.6% | $10.9M+7.1% | $10.2M+9.5% | $9.3M |
| Current Assets | $12.6M+7.8% | $11.7M+26.4% | $9.3M+16.1% | $8.0M-22.9% | $10.3M+28.0% | $8.1M+9.6% | $7.4M+14.3% | $6.4M |
| Cash & Equivalents | $5.0M+21.8% | $4.1M-13.8% | $4.7M+45.8% | $3.3M-45.4% | $6.0M+17.8% | $5.1M+4.7% | $4.8M+15.6% | $4.2M |
| Inventory | $4.7M+21.3% | $3.9M+41.7% | $2.7M-19.1% | $3.4M+44.3% | $2.4M+13.6% | $2.1M+57.8% | $1.3M-4.1% | $1.4M |
| Accounts Receivable | $2.4M-12.2% | $2.8M+246.7% | $801K+57.2% | $510K-46.5% | $953K+109.1% | $456K+9.3% | $417K-8.3% | $455K |
| Goodwill | $2.2M0.0% | $2.2M0.0% | $2.2M0.0% | $2.2M0.0% | $2.2M0.0% | $2.2M0.0% | $2.2M0.0% | $2.2M |
| Total Liabilities | $5.2M0.0% | $5.2M+56.7% | $3.3M+0.5% | $3.3M-36.7% | $5.2M+29.2% | $4.0M+14.6% | $3.5M+1.9% | $3.4M |
| Current Liabilities | $4.6M+1.4% | $4.5M+84.3% | $2.4M-12.4% | $2.8M-37.5% | $4.5M+30.6% | $3.4M+20.1% | $2.9M0.0% | $2.9M |
| Long-Term Debt | $138K-0.6% | $139K-1.2% | $141K-3.8% | $147K | N/A | N/A | $173K | N/A |
| Total Equity | $11.1M+8.7% | $10.2M+5.6% | $9.7M+25.5% | $7.7M-3.2% | $7.9M+15.5% | $6.9M+3.1% | $6.7M+13.9% | $5.9M |
| Retained Earnings | $1.8M+66.8% | $1.1M+9.2% | $966K+819.7% | -$134K+94.1% | -$2.3M+30.7% | -$3.3M+4.5% | -$3.5M+18.0% | -$4.2M |
AXIL Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q3'25 | Q2'24 | Q2'25 | Q1'24 | Q2'23 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $935K+226.5% | -$739K-335.0% | -$170K+49.5% | -$337K-139.4% | $855K+115.3% | $397K-33.6% | $598K+383.2% | $124K |
| Capital Expenditures | $28K+240.0% | $8K-94.4% | $148K+154.3% | $58K+192.9% | $20K-61.0% | $51K+246.9% | $15K+30.6% | $11K |
| Free Cash Flow | $906K+221.2% | -$748K-135.0% | -$318K+19.4% | -$395K-147.3% | $835K+141.2% | $346K-40.7% | $583K+418.5% | $113K |
| Investing Cash Flow | -$41K+56.8% | -$94K+36.2% | -$148K-84.4% | -$80K-304.0% | -$20K+61.0% | -$51K | $0+100.0% | -$11K |
| Financing Cash Flow | -$5K-103.1% | $150K+198.8% | -$152K+87.5% | -$1.2M-1953.3% | $66K+156.0% | -$117K-316.2% | $54K+9.2% | $50K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
AXIL Financial Ratios
| Metric | Q2'26 | Q1'26 | Q3'25 | Q2'24 | Q2'25 | Q1'24 | Q2'23 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.1%+0.5pp | 67.6%-4.1pp | 71.7%-3.1pp | 74.9%+0.5pp | 74.3%-1.8pp | 76.1%-1.0pp | 77.2%+2.6pp | 74.6% |
| Operating Margin | 11.1%+5.1pp | 6.0%-2.4pp | 8.4%-6.2pp | 14.6%-0.4pp | 15.0%+12.2pp | 2.9%+3.9pp | -1.1%-4.9pp | 3.8% |
| Net Margin | 8.7%+3.8pp | 4.9%-3.4pp | 8.3%-2.5pp | 10.8%-1.3pp | 12.1%+9.6pp | 2.5%-3.2pp | 5.7%+2.8pp | 2.9% |
| Return on Equity | 6.4%+3.1pp | 3.3%-2.7pp | 6.0%-7.1pp | 13.1%+0.3pp | 12.8%+10.6pp | 2.3%-5.6pp | 7.9%+5.1pp | 2.8% |
| Return on Assets | 4.3%+2.2pp | 2.2%-2.3pp | 4.5%-2.8pp | 7.2%-0.5pp | 7.8%+6.3pp | 1.4%-1.2pp | 2.7%+0.9pp | 1.7% |
| Current Ratio | 2.75+0.2 | 2.59-1.2 | 3.78+0.9 | 2.85+0.5 | 2.31-0.0 | 2.35-0.2 | 2.58+0.3 | 2.26 |
| Debt-to-Equity | 0.010.0 | 0.010.0 | 0.010.0 | 0.02-0.6 | 0.65+0.1 | 0.58+0.6 | 0.03-0.6 | 0.59 |
| FCF Margin | 11.1%+22.0pp | -10.9%-6.3pp | -4.6%-24.4pp | 19.8%+9.9pp | 9.9%+4.3pp | 5.7% | N/A | 2.0% |
Similar Companies
Frequently Asked Questions
What is Axil Brands's annual revenue?
Axil Brands (AXIL) reported $26.3M in total revenue for fiscal year 2025. This represents a -4.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Axil Brands's revenue growing?
Axil Brands (AXIL) revenue declined by 4.5% year-over-year, from $27.5M to $26.3M in fiscal year 2025.
Is Axil Brands profitable?
Yes, Axil Brands (AXIL) reported a net income of $855K in fiscal year 2025, with a net profit margin of 3.3%.
What is Axil Brands's earnings per share (EPS)?
Axil Brands (AXIL) reported diluted earnings per share of $0.10 for fiscal year 2025. This represents a -52.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Axil Brands's EBITDA?
Axil Brands (AXIL) had EBITDA of $1.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Axil Brands have?
As of fiscal year 2025, Axil Brands (AXIL) had $4.8M in cash and equivalents against $140K in long-term debt.
What is Axil Brands's gross margin?
Axil Brands (AXIL) had a gross margin of 71.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Axil Brands's operating margin?
Axil Brands (AXIL) had an operating margin of 4.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Axil Brands's net profit margin?
Axil Brands (AXIL) had a net profit margin of 3.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Axil Brands's return on equity (ROE)?
Axil Brands (AXIL) has a return on equity of 8.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Axil Brands's free cash flow?
Axil Brands (AXIL) generated $1.7M in free cash flow during fiscal year 2025. This represents a 1363.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Axil Brands's operating cash flow?
Axil Brands (AXIL) generated $1.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Axil Brands's total assets?
Axil Brands (AXIL) had $12.9M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Axil Brands's capital expenditures?
Axil Brands (AXIL) invested $213K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How many shares does Axil Brands have outstanding?
Axil Brands (AXIL) had 7M shares outstanding as of fiscal year 2025.
What is Axil Brands's current ratio?
Axil Brands (AXIL) had a current ratio of 3.76 as of fiscal year 2025, which is generally considered healthy.
What is Axil Brands's debt-to-equity ratio?
Axil Brands (AXIL) had a debt-to-equity ratio of 0.01 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Axil Brands's return on assets (ROA)?
Axil Brands (AXIL) had a return on assets of 6.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Axil Brands's Altman Z-Score?
Axil Brands (AXIL) has an Altman Z-Score of 10.53, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Axil Brands's Piotroski F-Score?
Axil Brands (AXIL) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Axil Brands's earnings high quality?
Axil Brands (AXIL) has an earnings quality ratio of 2.26x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Axil Brands?
Axil Brands (AXIL) scores 51 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.